Creative Life Science CoROCO:7837 -3.29%20 Gross Margin % is 42.35% as of Dec. 2025, which is 4% above its 10-year median of 40.78. GuruFocus rates ROCO:7837 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 730 Biotechnology companies, Creative Life Science Co ranks worse than 68.36% on this metric.
Creative Life Science Co (ROCO:7837) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Creative Life Science Co had a gross margin of 42.35% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Creative Life Science Co Gross Margin % Related Terms
Creative Life Science Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7837 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Creative Life Science Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creative Life Science Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Creative Life Science Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Creative Life Science Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Creative Life Science Co (ROCO:7837) has a Gross Margin % of 42.35% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Creative Life Science Co and its competitors. This is near median its historical median of 40.78. Over the past decade, Creative Life Science Co's Gross Margin % has ranged from 36.96 to 41.08. According to the industry distribution chart, Creative Life Science Co ranks #499 out of 730 companies in the Biotechnology industry, placing it in the top 68.4%.
Is Creative Life Science Co's Gross Margin % too high?
Creative Life Science Co's current Gross Margin % of 42.35% is near median its 10-year median of 40.78. Over the past 10 years, this metric has ranged from a low of 36.96 to a high of 41.08. The Biotechnology industry median Gross Margin % is 60.91. Creative Life Science Co's value of 42.35% is 30.5% below this industry median. Based on the distribution chart, Creative Life Science Co ranks #499 out of 730 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Creative Life Science Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Creative Life Science Co ranks #499 out of 730 companies for Gross Margin %. This places Creative Life Science Co in the lower half of its industry. The industry median Gross Margin % is 60.91. Creative Life Science Co's value of 42.35% is 30.5% below this benchmark. Historically, Creative Life Science Co's own Gross Margin % has ranged from 36.96 to 41.08 over the past decade. While the company's 10-year median is 40.78 vs. the industry median of 60.91, Creative Life Science Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 730 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Creative Life Science Co's current Gross Margin % of 42.35% is 30.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Creative Life Science Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creative Life Science Co's current Gross Margin % is 42.35%, which is near median its own 10-year median of 40.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current Gross Margin % of 42.35%. The current Gross Margin % is 42.35%, which is near median its 10-year median of 40.78 and 30.5% below the Biotechnology industry median of 60.91. Creative Life Science Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current Gross Margin % is 42.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
20GF Score
Get the complete analysis for ROCO:7837
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7837 has been successfully added to your 